NCT05384951View on ClinicalTrials.gov

HMB Cerebral Palsy Pilot Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Cerebral Palsy
Interventions
DIETARY_SUPPLEMENT

HMB + Vitamin D3

The supplement will be taken orally twice daily. Participants will take 2 blended HMB + Vitamin D3 tablets in the morning and 2 tablets in the evening for 12 weeks.

Trial Locations (1)

55101

Gillette Children's Specialty Healthcare, Saint Paul

Sponsors
All Listed Sponsors
collaborator

University of Minnesota

OTHER

collaborator

Metabolic Technologies, LLC

UNKNOWN

lead

Gillette Children's Specialty Healthcare

OTHER